CureVac (CVAC) Stock Rises 25% on Positive Data for Covid-19 and Flu Vaccines

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

CureVac announced positive results for its mRNA-based Covid-19 and flu vaccine, which may offer tremendous relevance for CVAC stock.

The post CureVac (CVAC) Stock Rises 25% on Positive Data for Covid-19 and Flu Vaccines appeared first on InvestorPlace.

• Buy This $5 Stock BEFORE This Apple Project Goes Live
• The Best $1 Investment You Can Make Today
• Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air”
• It doesn’t matter if you have $500 or $5 million. Do this now.